This study demonstrated two important facts: the possibility for diagnosing contrast-induced acute kidney injury (CI-AKI) using new, more sensitive markers of kidney damage, which is important for assessing the effectiveness of prevention, and the possibility of using ARBs, in particular azilsartan, for the prevention of CI-AKI in patients with IHD in combination with AH and DM.
Keyphrases
- acute kidney injury
- cardiac surgery
- percutaneous coronary intervention
- randomized controlled trial
- systematic review
- oxidative stress
- acute coronary syndrome
- magnetic resonance
- st segment elevation myocardial infarction
- acute myocardial infarction
- coronary artery disease
- diabetic rats
- coronary artery bypass grafting
- st elevation myocardial infarction
- high glucose
- type diabetes
- metabolic syndrome
- high resolution
- mass spectrometry
- molecularly imprinted